Arkolith/Insider Trading/IRWD/Form 4

Shetzline Michael

SVP, CMO, Head-Res&DrugIRONWOOD PHARMACEUTICALS INC (IRWD) · full profile →Form 4 · filed Feb 25, 2026
Net Buying
Open-Market Buys
$62K
Open-Market Sells
$59K
Net Open-Market Flow
$3K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Buy(S)17K$3.66$62K521K
Feb 23, 2026Sell(S)16K$3.81$59K538K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-071503) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML